HGH and LL-37 Interaction

Synergistic
Mechanism-based 47% confidence

HGH and LL-37 have a synergistic interaction with 47% confidence. HGH and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

HGH

Human Growth Hormone | Somatropin

Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation.

Half-life: 3-4 hours (SC), 20-30 minutes (IV) Typical dose: 1-4 IU daily (0.33-1.33mg); start low and titrate up growth hormone, weight loss, healing
gh directigf1 carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

LL-37

Human Cathelicidin | Antimicrobial Peptide

Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..

Half-life: Short (rapid proteolytic degradation) Typical dose: 0.5-1.6 mg/mL topical gel or 100-150 mcg injectable immune, healing
View full profile

Combined Organ Load

Blood Vessels
low
GI Tract
low
Pituitary
low

Frequently Asked Questions

Can I take HGH with LL-37?

Yes, HGH and LL-37 can generally be taken together. HGH and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is HGH and LL-37 safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between HGH and LL-37?

HGH and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time HGH and LL-37?

HGH has a half-life of 3-4 hours (SC), 20-30 minutes (IV) and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: HGH vs LL-37

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.